I'm not sure how many people understand how consumption license work and impacts the revenue.
They book a big sum for module licensing upfront and almost book nothing (minimum usage)for consumption license just because it's impossible to predict how much data one company is gonna process. We will only see revenue going up if more data are being processed which IMO will definitely happen in the coming month/years.
- Forums
- ASX - By Stock
- NXL
- Ann: Nuix Revises FY21 Forecast Range
Ann: Nuix Revises FY21 Forecast Range, page-35
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.40 |
Change
-0.100(2.86%) |
Mkt cap ! $1.100B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.809M | 820.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2881 | $3.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.42 | 3213 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2881 | 3.360 |
1 | 2881 | 3.350 |
1 | 2881 | 3.340 |
1 | 300 | 3.330 |
3 | 13000 | 3.300 |
Price($) | Vol. | No. |
---|---|---|
3.420 | 3213 | 2 |
3.430 | 2881 | 1 |
3.440 | 2881 | 1 |
3.450 | 23920 | 2 |
3.480 | 6400 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online